|
 |
|
 |
 |
Name:
Sector:
Chief
Executive:
|
MiddleBrook Pharmaceuticals (formerly Advancis)
Healthcare
Edward M. Rudnic, PhD
|
|
|
Summary:
|
Therapeutically-focused and emerging pharmaceutical company
seeking to improve therapies for antibacterial and antiviral
agents. APC's technology is based on prolonged absorption systems
which functionally extend an anti-infective agent's therapeutic
activity, and deliver the drug more efficiently.
|
|
|
Stage of Initial
Investment:
|
Seed/Early and PIPE |
Liquidity:
|
IPO
(NASDAQ: MBRK)
|
| |
|
|
|
|
|
 |
| |
20425 Seneca Meadows Pkway
Germantown, MD 20876
Phone: 301.944.6600
Fax: 301.944.6700 |
|
 |
|
|
|
